Home
Conditions
Idiopathic Inflammatory Myopathies

Clinical trial condition

Idiopathic Inflammatory Myopathies

Explore clinical trials studying Idiopathic Inflammatory Myopathies. Study availability and eligibility vary by location and protocol.

34 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Idiopathic Inflammatory Myopathies trial results

Recruiting

AYLo - AutoimmunitY and Loss of y

NCT06696027

Conditions: ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +61 more
Locations: Department of Rheumatology Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

Optimizing Treatment on Idiopathic Inflammatory Myopathies

NCT03092180

Conditions: Antisynthetase syndrome, Connective Tissue Diseases, Dermatomyositis, +9 more
Locations: Samuel Katsuyuki Shinjo São Paulo, Brazil

View Trial Details

Recruiting

Biomarkers in Autoimmune Disease of Nervous System

NCT06502015

Conditions: Acute Disseminated Encephalomyelitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +43 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China

View Trial Details

Recruiting

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT04561557

Conditions: Abnormalities, Multiple, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +45 more
Locations: Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

NCT06350110

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Arthritis, +50 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

NCT06375993

Conditions: ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +33 more
Locations: Adicet Clinical Trials Redwood City, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Not Yet Recruiting

CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases

NCT07596680

Conditions: ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +32 more
Locations: Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Tongji NADs Cohort

NCT07333196

Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +40 more
Locations: Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

NCT06986018

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +14 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT06970951

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Idiopathic Inflammatory Myopathies

Idiopathic Inflammatory Myopathies trial results

Related conditions